2022-12-01 2023-11-30 false Capium Accounts Production 1.1 10470434 bus:AbridgedAccounts 2022-12-01 2023-11-30 10470434 bus:FRS102 2022-12-01 2023-11-30 10470434 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 10470434 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 10470434 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 10470434 2022-12-01 2023-11-30 10470434 2023-11-30 10470434 bus:RegisteredOffice 2022-12-01 2023-11-30 10470434 core:WithinOneYear 2023-11-30 10470434 core:AfterOneYear 2023-11-30 10470434 bus:Director1 2022-12-01 2023-11-30 10470434 bus:Director1 2023-11-30 10470434 bus:Director1 2021-12-01 2022-11-30 10470434 bus:Director2 2022-12-01 2023-11-30 10470434 bus:Director2 2023-11-30 10470434 bus:Director2 2021-12-01 2022-11-30 10470434 2021-12-01 10470434 bus:LeadAgentIfApplicable 2022-12-01 2023-11-30 10470434 2021-12-01 2022-11-30 10470434 2022-11-30 10470434 core:WithinOneYear 2022-11-30 10470434 core:AfterOneYear 2022-11-30 10470434 bus:EntityAccountantsOrAuditors 2021-12-01 2022-11-30 10470434 bus:OrdinaryShareClass1 2022-12-01 2023-11-30 10470434 bus:OrdinaryShareClass1 2023-11-30 10470434 bus:OrdinaryShareClass1 2021-12-01 2022-11-30 10470434 bus:OrdinaryShareClass1 2022-11-30 10470434 core:LandBuildings 2022-12-01 2023-11-30 10470434 core:LandBuildings 2023-11-30 10470434 core:LandBuildings 2022-11-30 10470434 core:MotorCars 2022-12-01 2023-11-30 10470434 core:MotorCars 2023-11-30 10470434 core:MotorCars 2022-11-30 10470434 core:FurnitureFittings 2022-12-01 2023-11-30 10470434 core:FurnitureFittings 2023-11-30 10470434 core:FurnitureFittings 2022-11-30 10470434 core:ComputerEquipment 2022-12-01 2023-11-30 10470434 core:ComputerEquipment 2023-11-30 10470434 core:ComputerEquipment 2022-11-30 10470434 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-11-30 10470434 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-11-30 10470434 core:CostValuation core:Non-currentFinancialInstruments 2023-11-30 10470434 core:CostValuation core:Non-currentFinancialInstruments 2022-11-30 10470434 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-11-30 10470434 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 10470434 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 10470434 core:Non-currentFinancialInstruments 2023-11-30 10470434 core:Non-currentFinancialInstruments 2022-11-30 10470434 core:ShareCapital 2023-11-30 10470434 core:ShareCapital 2022-11-30 10470434 core:RetainedEarningsAccumulatedLosses 2023-11-30 10470434 core:RetainedEarningsAccumulatedLosses 2022-11-30 10470434 dpl:Item1 2022-12-01 10470434 dpl:Item1 2023-11-30 10470434 dpl:Item1 2021-12-01 10470434 dpl:Item1 2022-11-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10470434
England and Wales

 

 

 

REVIVE HEALTH CARE LTD


Abridged Accounts
 


Period of accounts

Start date: 01 December 2022

End date: 30 November 2023
Report to the directors on the preparation of the quarterly management accounts of REVIVE HEALTH CARE LTD for the quarter ended 30 November 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of REVIVE HEALTH CARE LTD for the year ended 30 November 2023 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the companys accounting records and from information and explanations you have given us
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at
http://rulebook.accaglobal.com/
This report is made solely to the Board of Directors of REVIVE HEALTH CARE LTD, as a body, in accordance with the terms of our engagement letter dated 23 August 2024 Our work has been undertaken solely to prepare for your approval the accounts of REVIVE HEALTH CARE LTD and state those matters that we have agreed to state to the Board of Directors of REVIVE HEALTH CARE LTD, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than REVIVE HEALTH CARE LTD and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that REVIVE HEALTH CARE LTD has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of REVIVE HEALTH CARE LTD. You consider that REVIVE HEALTH CARE LTD is exempt from the statutory audit requirement for the year
We have not been instructed to carry out an audit or a review of the accounts of REVIVE HEALTH CARE LTD. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts
30 November 2023



....................................................
SNP Plus Ltd
Accountants and Tax Advisors
284 Station Road
Harrow, London
HA1 2EA
23 August 2024
1
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Tangible fixed assets 3 769,952    596,926 
769,952    596,926 
Current assets      
Stocks 1,576    1,789 
Debtors 7,285    9,329 
Cash at bank and in hand 53,114    107,204 
61,975    118,322 
Creditors: amount falling due within one year (450,304)   (314,623)
Net current assets (388,329)   (196,301)
 
Total assets less current liabilities 381,623    400,625 
Creditors: amount falling due after more than one year (282,422)   (280,345)
Provisions for liabilities (34,254)   (11,036)
Net assets 64,947    109,244 
 

Capital and reserves
     
Called up share capital 4 100    400 
Profit and loss account 64,847    108,844 
Shareholders' funds 64,947    109,244 
 


For the year ended 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 23 August 2024 and were signed on its behalf by:


-------------------------------
Ashwin Nepal
Director
2
General Information
REVIVE HEALTH CARE LTD is a private company, limited by shares, registered in England and Wales, registration number 10470434, registration address 284 Station Road, Harrow, HA1 2EA.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company. The revenue is recognized as soon as invoice is raised.
Website cost
Planning and operating costs for the company's website are charged to the income statement as incurred.
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Motor Vehicles 10% Straight Line
Fixtures and Fittings 20% Straight Line
Computer Equipment 20% Straight Line
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.

Average number of employees

Average number of employees during the year was 19 (2022 : 20).
3.

Tangible fixed assets

Cost or valuation Land and Buildings   Motor Vehicles   Fixtures and Fittings   Computer Equipment   Total
  £   £   £   £   £
At 01 December 2022 544,500    3,450    80,323    1,978    630,251 
Additions 47,250      177,078    383    224,711 
Disposals        
At 30 November 2023 591,750    3,450    257,401    2,361    854,962 
Depreciation
At 01 December 2022   2,070    30,431    824    33,325 
Charge for year   345    50,868    472    51,685 
On disposals        
At 30 November 2023   2,415    81,299    1,296    85,010 
Net book values
Closing balance as at 30 November 2023 591,750    1,035    176,102    1,065    769,952 
Opening balance as at 01 December 2022 544,500    1,380    49,892    1,154    596,926 


4.

Share Capital

Allotted, called up and fully paid
2023
£
  2022
£
400 Class A shares of £1.00 each 400    400 
400    400 

5.

Related parties

During the year the company entered into the following transactions with related parties:
Transaction value - income/(expenses) Balance owed by/(owed to)
2023
£
 2022
£
 2023
£
 2022
£
Ashwin Nepal18,923 1,326 
3